Research Solutions, Inc. financial data

Symbol
RSSS on Nasdaq
Location
10624 S. Eastern Ave, Suite A 614, Henderson, NV
State of incorporation
NV
Fiscal year end
June 30
Former names
Derycz Scientific Inc (to 2/22/2013)
Latest financial report
10-Q - Q4 2024 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 80.1 % -31.8%
Debt-to-equity 236 %
Return On Equity -32.6 % -558%
Return On Assets -9.73 % -498%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.6M shares +0.08%
Common Stock, Shares, Outstanding 32.6M shares +0.06%
Entity Public Float 68.8M USD +54.4%
Common Stock, Value, Issued 32.6K USD +0.06%
Weighted Average Number of Shares Outstanding, Basic 30.4M shares +8.29%
Weighted Average Number of Shares Outstanding, Diluted 30.4M shares +8.29%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 48.2M USD +18.5%
Operating Income (Loss) 1.49M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.92M USD -908%
Income Tax Expense (Benefit) 135K USD +236%
Net Income (Loss) Attributable to Parent -4.06M USD -845%
Earnings Per Share, Basic -0.07 USD/shares
Earnings Per Share, Diluted -0.07 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.7M USD +185%
Accounts Receivable, after Allowance for Credit Loss, Current 7.12M USD -2.38%
Assets, Current 16.1M USD +39%
Property, Plant and Equipment, Net 63.4K USD -38.6%
Goodwill 16.3M USD -0.65%
Assets 42.8M USD +8.43%
Liabilities, Current 20.9M USD +25.2%
Liabilities 31.7M USD +24.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -122K USD -8.45%
Retained Earnings (Accumulated Deficit) -27.6M USD -17.2%
Stockholders' Equity Attributable to Parent 11.1M USD -20.3%
Liabilities and Equity 42.8M USD +8.43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 843K USD
Net Cash Provided by (Used in) Financing Activities -16.1K USD +89.7%
Net Cash Provided by (Used in) Investing Activities -2.75M USD -814%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 32.6M shares +0.06%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 825K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.7M USD +185%
Deferred Tax Assets, Valuation Allowance 3.13M USD -34.5%
Deferred Tax Assets, Gross 5.52M USD +13.7%
Payments to Acquire Property, Plant, and Equipment 33.8K USD +819%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.07M USD -865%
Property, Plant and Equipment, Gross 1.01M USD +6.14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 38.8M USD +3.27%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 312K USD +423%
Deferred Tax Assets, Net of Valuation Allowance 3.13M USD -34.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%